Lyophilized formulations and compositions containing bone morphogenetic protein which has been stabilized by lyophilisation can contain primarily trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.